OppenheimerFunds, Inc. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 205 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2019. The put-call ratio across all filers is 1.21 and the average weighting 0.6%.

Quarter-by-quarter ownership
OppenheimerFunds, Inc. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q1 2019$136,957,000
+49.0%
1,710,895
+0.3%
0.17%
+29.8%
Q4 2018$91,927,000
-29.4%
1,705,175
+2.2%
0.13%
-13.2%
Q3 2018$130,265,000
+22.3%
1,668,781
-0.5%
0.15%
+18.9%
Q2 2018$106,503,000
-28.0%
1,677,731
+4.0%
0.13%
-31.4%
Q1 2018$147,970,000
+20.2%
1,613,636
-1.1%
0.18%
+24.2%
Q4 2017$123,070,000
+17.4%
1,632,006
+8.4%
0.15%
+15.5%
Q3 2017$104,871,000
+35.7%
1,505,254
-1.3%
0.13%
+35.8%
Q2 2017$77,272,000
+199.4%
1,525,002
+136.3%
0.10%
+206.5%
Q1 2017$25,810,000645,3970.03%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2019
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders